SCHEMBL20199481

SCHEMBL20199481

c1ccc2c(c1)-c1ccccc1C21c2cc3c4ccccc4n(-c4ccc5oc6ccccc6c5c4)c3cc2C2(c3ccccc3-c3ccccc32)c2cc3c4ccccc4n(-c4ccc5oc6ccccc6c5c4)c3cc21

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 2/20 0.35
MAPT P10636 2/20 0.35
AHR P35869 2/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
CHRNA7 P36544 1/20 0.31
KCNH2 Q12809 1/20 0.31
PGR P06401 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20199454 0.99 KDM4E (0.35) KDM4ESMN1; SMN2NPC1MAPTAHR
SCHEMBL16376457 0.94 KDM4E (0.38) KDM4ESMN1; SMN2NPC1MAPTAHR
SCHEMBL25098651 0.94 KDM4E (0.38) KDM4ESMN1; SMN2NPC1MAPTAHR
SCHEMBL14822246 0.94 KDM4E (0.38) KDM4ESMN1; SMN2NPC1MAPTAHR
SCHEMBL20203629 0.93 KDM4E (0.35) KDM4ESMN1; SMN2NPC1MAPTAHR
SCHEMBL20199508 0.93 KDM4E (0.37) KDM4ESMN1; SMN2NPC1MAPTAHR
SCHEMBL20199586 0.93 KDM4E (0.37) KDM4ESMN1; SMN2NPC1MAPTAHR
SCHEMBL23183928 0.89 AHR (0.32) KDM4ESMN1; SMN2NPC1MAPTAHR
SCHEMBL23184987 0.89 AHR (0.32) KDM4ESMN1; SMN2NPC1MAPTAHR
SCHEMBL23184197 0.87 AHR (0.30) KDM4ESMN1; SMN2NPC1MAPTAHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001752-B2 Double spiro organic compound and organic electronic element comprising same LG CHEM, LTD. (KR) 2021-05-11 US disclosed
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-31 US disclosed
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11001752-B2 Double spiro organic compound and organic electronic element comprising same DCX, TERT, TELO2 KDM4E 1392/4885SMN1; SMN2 121/4885NPC1 3193/4885
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME DCX, TERT, TELO2 KDM4E 1392/4885SMN1; SMN2 121/4885NPC1 3193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.